A pivotal role for the IL-1β and the inflammasome in preterm labor.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 Feb 2024
Historique:
received: 12 12 2023
accepted: 13 02 2024
medline: 21 2 2024
pubmed: 21 2 2024
entrez: 20 2 2024
Statut: epublish

Résumé

During labor, monocytes infiltrate massively the myometrium and differentiate into macrophages secreting high levels of reactive oxygen species and of pro-inflammatory cytokines (i.e. IL-1β), leading to myometrial contraction. Although IL-1β is clearly implicated in labor, its function and that of the inflammasome complex that cleaves the cytokine in its active form, has never been studied on steps preceding contraction. In this work, we used our model of lipopolysaccharide-induced preterm labor to highlight their role. We demonstrated that IL-1β was secreted by the human myometrium during labor or in presence of infection and was essential for myometrial efficient contractions as its blockage with an IL-1 receptor antagonist (Anakinra) or a neutralizing antibody completely inhibited the induced contractions. We evaluated the implication of the inflammasome on myometrial contractions and differentiation stages of labor onset. We showed that the effects of macrophage-released IL-1β in myometrial cell transactivation were blocked by inhibition of the inflammasome, suggesting that the inflammasome by producing IL-1β was essential in macrophage/myocyte crosstalk during labor. These findings provide novel innovative approaches in the management of preterm labor, specifically the use of an inflammasome inhibitor to block the precursor stages of labor before the acquisition of the contractile phenotype.

Identifiants

pubmed: 38378749
doi: 10.1038/s41598-024-54507-w
pii: 10.1038/s41598-024-54507-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4234

Subventions

Organisme : Institut National Du Cancer
ID : INCa PLBIO-22-093
Organisme : Institut National Du Cancer
ID : PLBIO21-107
Organisme : Investissements d'Avenir
ID : ANR-11-LABX-0021

Informations de copyright

© 2024. The Author(s).

Références

Blencowe, H. et al. Born too soon: The global epidemiology of 15 million preterm births. Reprod. Health 10 Suppl 1, S2 (2013).
pubmed: 24625129 doi: 10.1186/1742-4755-10-S1-S2
Goldenberg, R. L., Culhane, J. F., Iams, J. D. & Romero, R. Epidemiology and causes of preterm birth. Lancet 371, 75–84 (2008).
pubmed: 18177778 pmcid: 7134569 doi: 10.1016/S0140-6736(08)60074-4
Goldenberg, R. L., Hauth, J. C. & Andrews, W. W. Intrauterine infection and preterm delivery. N. Engl. J. Med. 342, 1500–1507 (2000).
pubmed: 10816189 doi: 10.1056/NEJM200005183422007
Dudley, D. J. Pre-term labor: An intra-uterine inflammatory response syndrome?. J. Reprod. Immunol. 36, 93–109 (1997).
pubmed: 9430741 doi: 10.1016/S0165-0378(97)00065-X
Christiaens, I. et al. Inflammatory processes in preterm and term parturition. J. Reprod. Immunol. 79, 50–57 (2008).
pubmed: 18550178 doi: 10.1016/j.jri.2008.04.002
Muglia, L. J. & Katz, M. The enigma of spontaneous preterm birth. N. Engl. J. Med. 362, 529–535 (2010).
pubmed: 20147718 doi: 10.1056/NEJMra0904308
Shynlova, O., Tsui, P., Jaffer, S. & Lye, S. J. Integration of endocrine and mechanical signals in the regulation of myometrial functions during pregnancy and labour. Eur. J. Obstet. Gynecol. Reprod. Biol. 144(Suppl 1), S2-10 (2009).
pubmed: 19299064 doi: 10.1016/j.ejogrb.2009.02.044
Bardou, M. et al. Systemic increase in human maternal circulating CD14+CD16- MCP-1+ monocytes as a marker of labor. Am. J. Obstet. Gynecol. 210(70), e1-9 (2014).
Yuan, M., Jordan, F., McInnes, I. B., Harnett, M. M. & Norman, J. E. Leukocytes are primed in peripheral blood for activation during term and preterm labour. Mol. Hum. Reprod. 15, 713–724 (2009).
pubmed: 19628509 pmcid: 2762373 doi: 10.1093/molehr/gap054
Pavlov, O., Pavlova, O., Ailamazyan, E. & Selkov, S. Characterization of cytokine production by human term placenta macrophages in vitro. Am. J. Reprod. Immunol. 60, 556–567 (2008).
pubmed: 18853988 doi: 10.1111/j.1600-0897.2008.00657.x
Young, A. et al. Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term. Biol. Reprod. 66, 445–449 (2002).
pubmed: 11804961 doi: 10.1095/biolreprod66.2.445
Hadi, T. et al. Glutathione prevents preterm parturition and fetal death by targeting macrophage-induced reactive oxygen species production in the myometrium. FASEB J. 29, 2653–2666 (2015).
pubmed: 25757563 doi: 10.1096/fj.14-266783
Wendremaire, M. et al. Macrophage-induced reactive oxygen species promote myometrial contraction and labor-associated mechanisms. Biol. Reprod. 102, 1326–1339 (2020).
pubmed: 32167534 doi: 10.1093/biolre/ioaa032
Shynlova, O., Nadeem, L., Zhang, J., Dunk, C. & Lye, S. Myometrial activation: Novel concepts underlying labor. Placenta 92, 28–36 (2020).
pubmed: 32056784 doi: 10.1016/j.placenta.2020.02.005
Gibbs, R. S., Romero, R., Hillier, S. L., Eschenbach, D. A. & Sweet, R. L. A review of premature birth and subclinical infection. Am. J. Obstet. Gynecol. 166, 1515–1528 (1992).
pubmed: 1595807 doi: 10.1016/0002-9378(92)91628-N
Gomez, R., Romero, R., Edwin, S. S. & David, C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect. Dis. Clin. N. Am. 11, 135–176 (1997).
doi: 10.1016/S0891-5520(05)70347-0
Yan, X., WuXiao, C., Sun, M., Tsang, B. K. & Gibb, W. Nuclear factor kappa B activation and regulation of cyclooxygenase Type-2 expression in human amnion mesenchymal cells by interleukin-1β1. Biol. Reprod. 66, 1667–1671 (2002).
pubmed: 12021045 doi: 10.1095/biolreprod66.6.1667
Zaragoza, D. B., Wilson, R. R., Mitchell, B. F. & Olson, D. M. The interleukin 1beta-induced expression of human prostaglandin F2alpha receptor messenger RNA in human myometrial-derived ULTR cells requires the transcription factor, NFkappaB1. Biol. Reprod. 75, 697–704 (2006).
pubmed: 16855208 doi: 10.1095/biolreprod.106.053439
Roberson, A. E., Hyatt, K., Kenkel, C., Hanson, K. & Myers, D. A. Interleukin 1β regulates progesterone metabolism in human cervical fibroblasts. Reprod. Sci. 19, 271–281 (2012).
pubmed: 22064385 doi: 10.1177/1933719111419246
Friebe-Hoffmann, U., Chiao, J. P. & Rauk, P. N. Effect of IL-1beta and IL-6 on oxytocin secretion in human uterine smooth muscle cells. Am. J. Reprod. Immunol. 46, 226–231 (2001).
pubmed: 11554696 doi: 10.1034/j.1600-0897.2001.d01-6.x
Rauk, P. N., Friebe-Hoffmann, U., Chiao, J.-P., Rauk, P. N. & Winebrenner, L. D. Interleukin-6 up-regulates the oxytocin receptor in cultured uterine smooth muscle cells. Am. J. Reprod. Immunol. 45, 148–153 (2001).
pubmed: 11270639 doi: 10.1111/j.8755-8920.2001.450305.x
Gargano, J. W. et al. Mid-pregnancy circulating cytokine levels, histologic chorioamnionitis and spontaneous preterm birth. J. Reprod. Immunol. 79, 100–110 (2008).
pubmed: 18814919 pmcid: 2683663 doi: 10.1016/j.jri.2008.08.006
Romero, R. et al. The natural interleukin-1 receptor antagonist in term and preterm parturition. Am. J. Obstet. Gynecol. 167, 863–872 (1992).
pubmed: 1415417 doi: 10.1016/S0002-9378(12)80003-2
Romero, R., Mazor, M. & Tartakovsky, B. Systemic administration of interleukin-1 induces preterm parturition in mice. Am. J. Obstet. Gynecol. 165, 969–971 (1991).
pubmed: 1951564 doi: 10.1016/0002-9378(91)90450-6
Sadowsky, D. W., Adams, K. M., Gravett, M. G., Witkin, S. S. & Novy, M. J. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am. J. Obstet. Gynecol. 195, 1578–1589 (2006).
pubmed: 17132473 doi: 10.1016/j.ajog.2006.06.072
Dinarello, C. A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519–550 (2009).
pubmed: 19302047 doi: 10.1146/annurev.immunol.021908.132612
Sims, J. E. & Smith, D. E. The IL-1 family: Regulators of immunity. Nat. Rev. Immunol. 10, 89–102 (2010).
pubmed: 20081871 doi: 10.1038/nri2691
Lamkanfi, M. & Dixit, V. M. Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 28, 137–161 (2012).
pubmed: 22974247 doi: 10.1146/annurev-cellbio-101011-155745
Lamkanfi, M. & Dixit, V. M. Mechanisms and functions of inflammasomes. Cell 157, 1013–1022 (2014).
pubmed: 24855941 doi: 10.1016/j.cell.2014.04.007
Jin, Y., Birlea, S. A., Fain, P. R. & Spritz, R. A. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J. Invest. Dermatol. 127, 2558–2562 (2007).
pubmed: 17637824 doi: 10.1038/sj.jid.5700953
Jin, Y. et al. NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 356, 1216–1225 (2007).
pubmed: 17377159 doi: 10.1056/NEJMoa061592
Xue, F., Wang, Y., Tao, X.-Q. & Su, W. A study on the level of NLRP3 inflammasome in patients with premature rupture of membranes. Immun. Inflamm. Dis. 11, e1018 (2023).
pubmed: 37773714 pmcid: 10510464 doi: 10.1002/iid3.1018
Motomura, K. et al. Fetal and maternal NLRP3 signaling is required for preterm labor and birth. JCI Insight 7, e158238 (2022).
pubmed: 35993366 pmcid: 9462488 doi: 10.1172/jci.insight.158238
Galaz, J. et al. A key role for NLRP3 signaling in preterm labor and birth driven by the alarmin S100B. Transl. Res. 259, 46–61 (2023).
pubmed: 37121539 doi: 10.1016/j.trsl.2023.04.004
Chen, Z. et al. NLRP3 inflammasome is involved in uterine activation for labor at term and preterm. Reproduction 162, 449–460 (2021).
pubmed: 34718231 doi: 10.1530/REP-21-0047
Lappas, M. Caspase-1 activation is increased with human labour in foetal membranes and myometrium and mediates infection-induced interleukin-1β secretion. Am. J. Reprod. Immunol. 71, 189–201 (2014).
pubmed: 24238269 doi: 10.1111/aji.12174
Breuiller-Fouché, M. et al. Secreted surfactant protein A from fetal membranes induces stress fibers in cultured human myometrial cells. Am. J. Physiol. Endocrinol. Metab. 298, E1188–E1197 (2010).
pubmed: 20233942 doi: 10.1152/ajpendo.00746.2009
Yu, J. T. & López Bernal, A. The cytoskeleton of human myometrial cells. J. Reprod. Fertil. 112, 185–198 (1998).
pubmed: 9538344 doi: 10.1530/jrf.0.1120185
Yoshimura, K. & Hirsch, E. Effect of stimulation and antagonism of interleukin-1 signaling on preterm delivery in mice. J. Soc. Gynecol. Investig. 12, 533–538 (2005).
pubmed: 16202930 doi: 10.1016/j.jsgi.2005.06.006
Jovic, N. et al. The expression of IL-1β correlates with the expression of galectin-3 in the tissue at the maternal-fetal interface during the term and preterm labor. J. Clin. Med. 11, 6521 (2022).
pubmed: 36362749 pmcid: 9656499 doi: 10.3390/jcm11216521
Breuiller-Fouché, M. et al. Regulation of the endothelin/endothelin receptor system by interleukin-1β in human myometrial cells. Endocrinology 146, 4878–4886 (2005).
pubmed: 16109787 doi: 10.1210/en.2005-0250
Charpigny, G. et al. A functional genomic study to identify differential gene expression in the preterm and term human myometrium. Biol. Reprod. 68, 2289–2296 (2003).
pubmed: 12606369 doi: 10.1095/biolreprod.102.013763
Faro, J. et al. Intra-amniotic inflammation induces preterm birth by activating the NLRP3 inflammasome. Biol. Reprod. 100, 1290–1305 (2019).
pubmed: 30590393 doi: 10.1093/biolre/ioy261
Gomez-Lopez, N. et al. Macrophages exert homeostatic actions in pregnancy to protect against preterm birth and fetal inflammatory injury. JCI Insight 6, 25 (2021).
doi: 10.1172/jci.insight.146089
Hamilton, S. et al. Macrophages infiltrate the human and rat decidua during term and preterm labor: Evidence that decidual inflammation precedes labor. Biol. Reprod. 86, 39 (2012).
pubmed: 22011391 doi: 10.1095/biolreprod.111.095505
Gomez-Lopez, N., StLouis, D., Lehr, M. A., Sanchez-Rodriguez, E. N. & Arenas-Hernandez, M. Immune cells in term and preterm labor. Cell Mol. Immunol. 11, 571–581 (2014).
pubmed: 24954221 pmcid: 4220837 doi: 10.1038/cmi.2014.46
Abais, J. M., Xia, M., Zhang, Y., Boini, K. M. & Li, P.-L. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?. Antioxid. Redox Signal. 22, 1111–1129 (2015).
pubmed: 25330206 pmcid: 4403231 doi: 10.1089/ars.2014.5994
van de Veerdonk, F. L. et al. Reactive oxygen species–independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease. Proc. Natl. Acad. Sci. USA 107, 3030–3033 (2010).
pubmed: 20133696 pmcid: 2840365 doi: 10.1073/pnas.0914795107
Herb, M. & Schramm, M. Functions of ROS in macrophages and antimicrobial immunity. Antioxidants (Basel) 10, 313 (2021).
pubmed: 33669824 doi: 10.3390/antiox10020313
Wilson, A. et al. Tocolytics for delaying preterm birth: A network meta-analysis (0924). Cochrane Database Syst. Rev. 8, CD014978 (2022).
pubmed: 35947046
Navathe, R. & Berghella, V. Tocolysis for acute preterm labor: Where have we been, where are we now, and where are we going?. Am. J. Perinatol. 33, 229–235 (2016).
pubmed: 26808195 doi: 10.1055/s-0035-1571147
Hadi, T. et al. Biphasic Erk1/2 activation sequentially involving Gs and Gi signaling is required in beta3-adrenergic receptor-induced primary smooth muscle cell proliferation. Biochim. Biophys. Acta 1833, 1041–1051 (2013).
pubmed: 23388888 doi: 10.1016/j.bbamcr.2013.01.019
Wendremaire, M. et al. Leptin-induced HLA-G inhibits myometrial contraction and differentiation. Cells 11, 954 (2022).
pubmed: 35326405 pmcid: 8946078 doi: 10.3390/cells11060954
Renthal, N. E. et al. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc. Natl. Acad. Sci. USA 107, 20828–20833 (2010).
pubmed: 21079000 pmcid: 2996411 doi: 10.1073/pnas.1008301107
Shynlova, O., Nadeem, L., Dorogin, A., Mesiano, S. & Lye, S. J. The selective progesterone receptor modulator-promegestone-delays term parturition and prevents systemic inflammation-mediated preterm birth in mice. Am. J. Obstet. Gynecol. 226(249), e1-249.e21 (2022).
Reinebrant, H. E. et al. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst. Rev. 2015, CD001992 (2015).
pubmed: 26042617 pmcid: 7068172
Norton, M. E., Merrill, J., Cooper, B. A., Kuller, J. A. & Clyman, R. I. Neonatal complications after the administration of indomethacin for preterm labor. N. Engl. J. Med. 329, 1602–1607 (1993).
pubmed: 8232428 doi: 10.1056/NEJM199311253292202
McGoldrick, E., Stewart, F., Parker, R. & Dalziel, S. R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst. Rev. 12, CD004454 (2020).
pubmed: 33368142
Carson, R., Monaghan-Nichols, A. P., DeFranco, D. B. & Rudine, A. C. Effects of antenatal glucocorticoids on the developing brain. Steroids 114, 25–32 (2016).
pubmed: 27343976 pmcid: 5052110 doi: 10.1016/j.steroids.2016.05.012
Kimura, T. et al. What knockout mice can tell us about parturition. Rev. Reprod. 4, 73–80 (1999).
pubmed: 10357094 doi: 10.1530/ror.0.0040073
Fidel, P. L. et al. Treatment with the interleukin-I receptor antagonist and soluble tumor necrosis factor receptor Fc fusion protein does not prevent endotoxin-induced preterm parturition in mice. J. Soc. Gynecol. Investig. 4, 22–26 (1997).
pubmed: 9051630 doi: 10.1177/107155769700400104
Leitner, K. et al. IL-1 receptor blockade prevents fetal cortical brain injury but not preterm birth in a mouse model of inflammation-induced preterm birth and perinatal brain injury. Am. J. Reprod. Immunol. 71, 418–426 (2014).
pubmed: 24592965 pmcid: 3989434 doi: 10.1111/aji.12216
Gomez-Lopez, N. et al. Inhibition of the NLRP3 inflammasome can prevent sterile intra-amniotic inflammation, preterm labor/birth, and adverse neonatal outcomes. Biol. Reprod. 100, 1306–1318 (2019).
pubmed: 30596885 doi: 10.1093/biolre/ioy264
Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21, 248–255 (2015).
pubmed: 25686105 pmcid: 4392179 doi: 10.1038/nm.3806
Jiang, H. et al. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J. Exp. Med. 214, 3219–3238 (2017).
pubmed: 29021150 pmcid: 5679172 doi: 10.1084/jem.20171419
Coates, B. M. et al. Inhibition of the NOD-like receptor protein 3 inflammasome is protective in juvenile influenza A virus infection. Front. Immunol. 8, 782 (2017).
pubmed: 28740490 pmcid: 5502347 doi: 10.3389/fimmu.2017.00782
Marchetti, C. et al. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proc. Natl. Acad. Sci. USA 115, E1530–E1539 (2018).
pubmed: 29378952 pmcid: 5816172 doi: 10.1073/pnas.1716095115
Menck, K. et al. Isolation of human monocytes by double gradient centrifugation and their differentiation to macrophages in teflon-coated cell culture bags. J. Vis. Exp. https://doi.org/10.3791/51554 (2014).
doi: 10.3791/51554 pubmed: 25226391 pmcid: 4828059
Dallot, E. et al. Contraction of cultured human uterine smooth muscle cells after stimulation with endothelin-1. Biol. Reprod. 68, 937–942 (2003).
pubmed: 12604645 doi: 10.1095/biolreprod.102.008367
Babica, P., Sovadinová, I. & Upham, B. L. Scrape loading/dye transfer assay. Methods Mol. Biol. 1437, 133–144 (2016).
pubmed: 27207291 doi: 10.1007/978-1-4939-3664-9_9

Auteurs

T E Lopez (TE)

INSERM U1231, Labex LIPSTIC and Label of Excellence from la Ligue Nationale Contre le Cancer, 21000, Dijon, France.
Faculty of Medicine and Pharmacy, University of Burgundy, 21000, Dijon, France.

H Zhang (H)

INSERM U1231, Labex LIPSTIC and Label of Excellence from la Ligue Nationale Contre le Cancer, 21000, Dijon, France.
School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.

E Bouysse (E)

INSERM U1231, Labex LIPSTIC and Label of Excellence from la Ligue Nationale Contre le Cancer, 21000, Dijon, France.
Faculty of Medicine and Pharmacy, University of Burgundy, 21000, Dijon, France.

F Neiers (F)

Faculty of Medicine and Pharmacy, University of Burgundy, 21000, Dijon, France.

X Y Ye (XY)

School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.

C Garrido (C)

INSERM U1231, Labex LIPSTIC and Label of Excellence from la Ligue Nationale Contre le Cancer, 21000, Dijon, France.
Faculty of Medicine and Pharmacy, University of Burgundy, 21000, Dijon, France.
Cancer Center George-François Leclerc, 21000, Dijon, France.

M Wendremaire (M)

INSERM U1231, Labex LIPSTIC and Label of Excellence from la Ligue Nationale Contre le Cancer, 21000, Dijon, France.
Faculty of Medicine and Pharmacy, University of Burgundy, 21000, Dijon, France.

Frédéric Lirussi (F)

INSERM U1231, Labex LIPSTIC and Label of Excellence from la Ligue Nationale Contre le Cancer, 21000, Dijon, France. frederic.lirussi@univ-fcomte.fr.
Laboratory of Pharmacology-Toxicology, Platform PACE, University Hospital Besançon, 25000, Besançon, France. frederic.lirussi@univ-fcomte.fr.
Faculty of Medicine and Pharmacy, University of Franche-Comté, 25000, Besançon, France. frederic.lirussi@univ-fcomte.fr.

Classifications MeSH